ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,590Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 656

$1.54M Total Retail Price of All Prescriptions

Rank: 14 out of 656

1,015 Patients Receiving at Least One Drug in Part D
9%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

9% of this provider’s 918 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$133 was the average price of a prescription from this provider, compared to $147 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
RISPERIDONE 842 74 1 2
TRAZODONE HCL 800 72 2 1
BENZTROPINE MESYLATE 792 31 R 3 4
CITALOPRAM HBR 603 60 4 9
QUETIAPINE FUMARATE 412 48 5 5
DIVALPROEX SODIUM 389 18 6 24
SERTRALINE HCL 381 39 7 8
MIRTAZAPINE 341 34 8 13
LITHIUM CARBONATE 334 16 9 16
BUPROPION HCL SR 326 17 10 25
SEROQUEL 315 30 11 20
CLOZAPINE 300 0 12 31
FLUOXETINE HCL 299 42 13 11
ZOLPIDEM TARTRATE 298 11 14 3
OLANZAPINE 271 16 15 12
INVEGA SUSTENNA 266 0 16 39
HALOPERIDOL 237 34 17 26
LAMOTRIGINE 229 14 18 14
ABILIFY 228 13 19 6
BUSPIRONE HCL 219 28 20 19
CYMBALTA 199 16 21 7
AMANTADINE 187 43 22 77
GABAPENTIN 181 0 23 29
HYDROXYZINE PAMOATE 176 13 R 24 32
CARBAMAZEPINE 170 30 25 35
VENLAFAXINE HCL ER 161 14 26 15
PAROXETINE HCL 154 13 27 23
DOXEPIN HCL 154 11 27 41
DIVALPROEX SODIUM ER 146 0 29 10
AMITRIPTYLINE HCL 135 13 R 30 42
CHLORPROMAZINE HCL 132 14 31 55
PROPRANOLOL HCL 123 0 32 49
TRIHEXYPHENIDYL HCL 101 14 R 33 54
PERPHENAZINE 101 0 33 48
ZYPREXA 100 17 35 52
OXCARBAZEPINE 93 14 36 28
THIOTHIXENE 84 0 37 66
LOXAPINE 80 0 38 59
OLANZAPINE ODT 80 0 38 64
FLUPHENAZINE HCL 76 0 40 53
ZIPRASIDONE HCL 74 0 41 27
HALOPERIDOL DECANOATE 74 0 41 62
TOPIRAMATE 65 0 43 34
VALPROIC ACID 60 0 44 69
PRISTIQ ER 57 0 45 30
SEROQUEL XR 53 0 46 21
TRIFLUOPERAZINE HCL 52 12 47 72
ESCITALOPRAM OXALATE 50 0 48 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.